NASDAQ NMS - GLOBAL MARKET · GLMD
-1.97% · -$0.0850 · Vol 48.3K
Market closed · last close 4:00 PM ET · price as of 16:18:10 ET
Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd

Biotechnology
$4.22
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
GLMD
Galmed Pharmaceuticals Ltd
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GLMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GLMD catalysts
About Galmed Pharmaceuticals Ltd
Biotechnology
Listed since
2014
Employees
6
Country
IL

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.11
Day high
$4.13
Day low
$3.68
Previous close
$4.30
52W high
$12.88
-67.24% from high
52W low
$3.68
6% of range
Market cap
$4.5M
EPS
$-2.0692
Beta
0.96
Shares out
1M
Volume
48.3K
0.48× rel vol
Avg volume
99.7K
VWAP
$3.95
Price history computed in-house
1W
-5.84%
1M
+2.85%
3M
-14.92%
1Y
-62.59%
YTD
-29.71%
SMA 50 $4.50 · below
SMA 200 $5.59 · below
52W position 6%

GLMD overview

Veridion Score
59
Registered · 2026-08-24
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GLMD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GLMD Form 4 filings
Public disclosures

Congress activity in GLMD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for GLMD in the cached public ledger.

Federal contracts

GLMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GLMD in this window.
Lobbying spend

GLMD lobbying filings, year to date.

Registered lobbying filings matched to Galmed Pharmaceuticals Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GLMD in this window.
Loading news for GLMD
Analyst ratings
Sovereign unlock shows live analyst consensus for GLMD.
Options
Sovereign unlock shows live options positioning for GLMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.